CN
Genecast presented 3 studies at AACR 2022：
| ID | Title |
| N/A | Prediction of immune-checkpoint blockade response in gastrointestinal cancer patients using a machine learning-based RNA signature |
| 5150 | Multimodal Analysis of Plasma Cell-Free DNA Methylome for Sensitive Multi-Cancer Detection |
| 5189 | The potential of minimal residual disease (MRD) in guiding adjuvant therapy (AT) decisions in non-small cell lung cancer (NSCLC) |
#02-01/02, The Kendall, 50 Science Park Road. Singapore Science Park 2, Singapore 117406
Tel: +65 6047 0252 ; Email: info@genecast.com.sg
Copyright © 2014-2026 Genecast Group Inc. | Privacy Policy
